Randomised trial of the P2X3 receptor antagonist sivopixant for refractory chronic cough.
Eur Respir J. 2022 Jun 2;59(6):2100725. doi: 10.1183/13993003.00725-2021. Print 2022 Jun.
Eur Respir J. 2022.
PMID: 34649978
Free PMC article.
Clinical Trial.